Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
81.83 | 163 Cr | -53.09 | 2.57 | 0.00 | -9.29 | -5.26 | -2.47 | ||
63.99 | 151 Cr | -13.05 | 0.33 | 0.00 | -2.81 | 0.93 | -2.96 | ||
24.11 | 83 Cr | 29.08 | 1.46 | 0.00 | 5.01 | 4.64 | 4.27 | ||
54.40 | 59 Cr | -27.02 | 3.24 | 0.00 | -30.18 | -32.45 | -30.18 | ||
17.55 | 22 Cr | 12.47 | 1.44 | 0.00 | 0.00 | 0.00 | 2.57 | ||
22.70 | 16 Cr | -3.56 | 1.12 | 0.00 | -23.51 | -15.08 | -7.97 | ||
40.50 | 16 Cr | -10.90 | 1.92 | 0.00 | -17.77 | 0.86 | -3.87 | ||
| Median: 7 Co. | — | 40.50 | 59 Cr | -10.90 | 1.46 | 0.00 | -9.29 | 0.00 | -2.96 |
Bilcare Ltd is engaged in manufacturing specialty pharmaceutical packaging films, providing research services, and offering clinical services.
The company has a significant history of innovation, developing novel packaging solutions to protect moisture and oxygen-sensitive pharmaceuticals, reflecting its strong R&D capabilities.
In 2023, Bilcare strategically transferred its Pharma Packaging Division to Caprihans India Limited, freeing up resources for potential new business endeavors.
Bilcare operates unique production capacities, such as its Rajgurunagar plant, which is one of its kind in Asia and among only eight globally.
The acquisition of high-technology enterprise brand security provider Singular ID highlights Bilcare's commitment to integrating advanced technologies into its offerings.
Healthcare Services
Healthcare Research, Analytics & Technology
145 Cr
Moderate Risk
-12.6
59.2
—
0.3
116.00
50.00
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: May 28, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bilcare Ltd (BI) is currently trading at 61.59 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bilcare Ltd is engaged in manufacturing specialty pharmaceutical packaging films, providing research services, and offering clinical services. The company has a significant history of innovation, developing novel packaging solutions to protect moisture and oxygen-sensitive pharmaceuticals, reflecting its strong R&D capabilities. In 2023, Bilcare strategically transferred its Pharma Packaging Division to Caprihans India Limited, freeing up resources for potential new business endeavors. Bilcare operates unique production capacities, such as its Rajgurunagar plant, which is one of its kind in Asia and among only eight globally. The acquisition of high-technology enterprise brand security provider Singular ID highlights Bilcare's commitment to integrating advanced technologies into its offerings.
Over the past 52 weeks, Bilcare Ltd has traded between a low of ₹50.00 and a high of ₹116.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bilcare Ltd has a market capitalization of approximately 150.67. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bilcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -13.05 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 150.67 Cr, Bilcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bilcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bilcare Ltd is -13.05. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
4
Neutral
5
Bullish
5
Bearish
33
Neutral
5
Bullish
8
Bearish
29
Neutral
0
Bullish
3
Results Approval
Bilcare Ltd. will hold a Board meeting on 29 May 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended 31 March 2026; trading window closed until 48 hours after declaration.
Board Meeting - Results
Bilcare will hold a Board meeting on 29 May 2026 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026; trading window closed until 48 hrs after declaration.
